Medicare Prescription Drug Price Negotiation Act of 2017
Official title: A bill to amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate covered part D drug prices on behalf of Medicare beneficiaries.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Finance.
Medicare Prescription Drug Price Negotiation Act of 2017
This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits CMS from doing so.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 41: Medicare Prescription Drug Price Negotiation Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-S-41/
"S. 41: Medicare Prescription Drug Price Negotiation Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-41/.
S. 41, 115th Cong. (2026), https://openamerica.io/bill/115-S-41/.
[S. 41: Medicare Prescription Drug Price Negotiation Act of 2017](https://openamerica.io/bill/115-S-41/)